{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:48:07Z","timestamp":1790898487723,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jconrel.2022.09.010","type":"journal-article","created":{"date-parts":[[2022,9,24]],"date-time":"2022-09-24T13:00:36Z","timestamp":1664024436000},"page":"381-393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Local delivery of gambogic acid to improve anti-tumor immunity against oral squamous cell carcinoma"],"prefix":"10.1016","volume":"351","author":[{"given":"Xinmian","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Run","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Lin","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Jun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2022.09.010_bb0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc2982","article-title":"The molecular biology of head and neck cancer","volume":"11","author":"Leemans","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2022.09.010_bb0010","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrc.2018.11","article-title":"The molecular landscape of head and neck cancer","volume":"18","author":"Leemans","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2022.09.010_bb0015","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41571-019-0227-z","article-title":"The changing therapeutic landscape of head and neck cancer","volume":"16","author":"Cramer","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0020","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/s41392-021-00462-1","article-title":"Nanobody-based chimeric antigen receptor T cells designed by CRISPR\/Cas9 technology for solid tumor immunotherapy","volume":"6","author":"Mo","year":"2021","journal-title":"Signal Transduct Target Ther."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0025","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1158\/2159-8290.CD-20-0962","article-title":"A burned-out CD8(+) T-cell subset expands in the tumor microenvironment and curbs Cancer immunotherapy","volume":"11","author":"Sanmamed","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0030","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202101672","article-title":"Targeted anti-tumor immunotherapy using tumor infiltrating cells","author":"Xie","year":"2021","journal-title":"Adv Sci (Weinh)."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0035","doi-asserted-by":"crossref","first-page":"2009744","DOI":"10.1002\/adfm.202009744","article-title":"Antibody engineered platelets attracted by Bacteria-induced tumor-specific blood coagulation for checkpoint inhibitor immunotherapy","volume":"31","author":"Fan","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0040","first-page":"1","article-title":"Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy","volume":"6","author":"Tang","year":"2021","journal-title":"Signal Transduct Target Ther."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0045","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.1039\/D1NR00830G","article-title":"Non-depleting reformation of immunosuppressive myeloid cells to broaden the application of anti-PD therapy","volume":"13","author":"Peng","year":"2021","journal-title":"Nanoscale."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0050","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202000214","article-title":"Prodrug-based versatile nanomedicine for enhancing Cancer immunotherapy by increasing immunogenic cell death","volume":"16","author":"Bai","year":"2020","journal-title":"Small."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0055","doi-asserted-by":"crossref","first-page":"2011171","DOI":"10.1002\/adfm.202011171","article-title":"Nanomedicine-boosting tumor immunogenicity for enhanced immunotherapy","volume":"31","author":"Huang","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0060","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/JLB.3MR0320-444R","article-title":"Natural products and their derivatives: promising modulators of tumor immunotherapy","volume":"108","author":"Deng","year":"2020","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.115110","article-title":"Gambogenic acid induces ferroptosis in melanoma cells undergoing epithelial-to-mesenchymal transition","volume":"401","author":"Wang","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188381","article-title":"Gambogic acid: a shining natural compound to nanomedicine for cancer therapeutics","volume":"1874","author":"Hatami","year":"2020","journal-title":"Biochim Biophys Acta Rev Cancer."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0075","doi-asserted-by":"crossref","first-page":"17064","DOI":"10.1039\/D0NR03907A","article-title":"Rapid synthesis of a bi@ZIF-8 composite nanomaterial as a near-infrared-II (NIR-II) photothermal agent for the low-temperature photothermal therapy of hepatocellular carcinoma","volume":"12","author":"Li","year":"2020","journal-title":"Nanoscale."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0080","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/10717544.2018.1446474","article-title":"Cell penetrating peptides functionalized gambogic acid-nanostructured lipid carrier for cancer treatment","volume":"25","author":"Huang","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0085","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1158\/1078-0432.CCR-13-1063","article-title":"Gambogic acid induces apoptosis in imatinib-resistant chronic myeloid leukemia cells via inducing proteasome inhibition and caspase-dependent Bcr-Abl downregulation","volume":"20","author":"Shi","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0090","article-title":"A protein-fragment complementation assay reveals that celastrol and gambogic acid suppress ER\u03b1 mutants in breast cancer","volume":"188","author":"Xi","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0095","doi-asserted-by":"crossref","first-page":"994","DOI":"10.2174\/187152012802650066","article-title":"Gambogic acid is a novel anti-cancer agent that inhibits cell proliferation, angiogenesis and metastasis","volume":"12","author":"Wang","year":"2012","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0100","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.intimp.2008.05.013","article-title":"Gambogic acid induced tumor cell apoptosis by T lymphocyte activation in H22 transplanted mice","volume":"8","author":"Gu","year":"2008","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0105","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1166\/jbn.2018.2626","article-title":"Gambogic acid-loaded polymeric micelles for improved therapeutic effect in breast Cancer","volume":"14","author":"Wang","year":"2018","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0110","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1177\/1091581814523142","article-title":"Toxicity assessment of 7 anticancer compounds in zebrafish","volume":"33","author":"Gao","year":"2014","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202007910","article-title":"ATP-responsive smart hydrogel releasing immune adjuvant synchronized with repeated chemotherapy or radiotherapy to boost antitumor immunity","volume":"33","author":"Sun","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0120","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1039\/C8BM01442F","article-title":"Enhanced local cancer therapy using a CA4P and CDDP co-loaded polypeptide gel depot","volume":"7","author":"Yu","year":"2019","journal-title":"Biomater Sci."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0125","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.cclet.2020.10.016","article-title":"Drug-induced hierarchical self-assembly of poly(amino acid) for efficient intracellular drug delivery","volume":"32","author":"Li","year":"2021","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0130","first-page":"243","article-title":"Improving aqueous solubility and antitumor effects by nanosized gambogic acid-mPEG2000 micelles","volume":"9","author":"Cai","year":"2014","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.09.010_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.111581","article-title":"Injectable thermosensitive hydrogel-based drug delivery system for local cancer therapy","volume":"200","author":"Xiao","year":"2021","journal-title":"Colloids Surf B Biointerfaces."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113951","article-title":"Rationally designed drug delivery systems for the local treatment of resected glioblastoma","volume":"177","author":"Bastiancich","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0145","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jconrel.2021.07.031","article-title":"Does local drug delivery still hold therapeutic promise for brain cancer? A systematic review","volume":"337","author":"Bastiancich","year":"2021","journal-title":"J Control Release."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0150","doi-asserted-by":"crossref","DOI":"10.1002\/marc.202000507","article-title":"A novel temperature-dependent hydrogel emulsion with sol\/gel reversible phase transition behavior based on polystyrene-co-poly(N-isopropylacrylamide)\/poly(N-isopropylacrylamide) Core-Shell nanoparticle","volume":"42","author":"Jiang","year":"2021","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2021.461928","article-title":"In-situ grafting temperature-responsive hydrogel as a bifunctional solid-phase microextraction coating for tunable extraction of biomacromolecules","volume":"1639","author":"Qu","year":"2021","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jconrel.2022.09.010_bb0160","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ijbiomac.2019.04.131","article-title":"Polysaccharide and polypeptide based injectable thermo-sensitive hydrogels for local biomedical applications","volume":"133","author":"Darge","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0165","doi-asserted-by":"crossref","first-page":"19077","DOI":"10.1038\/srep19077","article-title":"Synthesis, characterization, and application of reversible PDLLA-PEG-PDLLA copolymer thermogels in vitro and in vivo","volume":"6","author":"Shi","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0170","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3390\/polym12020367","article-title":"Thermoresponsive poly(\u03b5-Caprolactone)-poly(ethylene\/propylene glycol) copolymers as injectable hydrogels for cell therapies","volume":"12","author":"Brewer","year":"2020","journal-title":"Polymers."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0175","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0169-409X(01)00244-7","article-title":"ABA-triblock copolymers from biodegradable polyester A-blocks and hydrophilic poly(ethylene oxide) B-blocks as a candidate for in situ forming hydrogel delivery systems for proteins","volume":"54","author":"Kissel","year":"2002","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0180","doi-asserted-by":"crossref","first-page":"2001442","DOI":"10.1002\/advs.202001442","article-title":"Injectable thermosensitive hydrogel containing Erlotinib-loaded hollow mesoporous silica nanoparticles as a localized drug delivery system for NSCLC therapy","volume":"7","author":"Zhou","year":"2020","journal-title":"Adv Sci (Weinh)."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0185","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.cell.2017.05.005","article-title":"Interferon-gamma drives Treg fragility to promote anti-tumor immunity","volume":"169","author":"Overacre-Delgoffe","year":"2017","journal-title":"Cell."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0190","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.smim.2014.01.008","article-title":"The two faces of IL-6 in the tumor microenvironment","volume":"26","author":"Fisher","year":"2014","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0195","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/1471-2407-9-343","article-title":"The NF-kappa B inhibitor, celastrol, could enhance the anti-cancer effect of gambogic acid on oral squamous cell carcinoma","volume":"9","author":"He","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jconrel.2022.09.010_bb0200","article-title":"Biodegradable thermosensitive hydrogel for SAHA and DDP delivery: therapeutic effects on oral squamous cell carcinoma xenografts","volume":"7","author":"Li","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2022.09.010_bb0205","doi-asserted-by":"crossref","first-page":"31264","DOI":"10.1039\/C9RA04343H","article-title":"MMP-responsive in situ forming hydrogel loaded with doxorubicin-encapsulated biodegradable micelles for local chemotherapy of oral squamous cell carcinoma","volume":"9","author":"Li","year":"2019","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0210","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2147\/IJN.S231448","article-title":"Antitumor activity of thermosensitive hydrogels packaging Gambogic acid nanoparticles and tumor-penetrating peptide iRGD against gastric cancer","volume":"15","author":"Zhang","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.09.010_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119568","article-title":"Near-infrared light and glucose dual-responsive cascading hydroxyl radical generation for in situ gelation and effective breast cancer treatment","volume":"228","author":"Hao","year":"2020","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0220","doi-asserted-by":"crossref","first-page":"9693","DOI":"10.1021\/acsnano.8b03800","article-title":"Enhanced transdermal drug delivery by transfersome-embedded oligopeptide hydrogel for topical chemotherapy of melanoma","volume":"12","author":"Jiang","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.09.010_bb0225","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1080\/10717544.2020.1739171","article-title":"Research progress in the application of in situ hydrogel system in tumor treatment","volume":"27","author":"Wei","year":"2020","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0230","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa1504627","article-title":"Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer","volume":"373","author":"Brahmer","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0235","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/mco2.8","article-title":"Engineered biomaterials for cancer immunotherapy","volume":"1","author":"Cai","year":"2020","journal-title":"MedComm."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0240","doi-asserted-by":"crossref","first-page":"12915","DOI":"10.1007\/s13277-016-5194-8","article-title":"Molecular targets of gambogic acid in cancer: recent trends and advancements","volume":"37","author":"Kashyap","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0245","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/978-3-319-41334-1_15","article-title":"Gambogic acid and its role in chronic diseases","volume":"928","author":"Pandey","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0250","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0255","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41586-019-1004-y","article-title":"Hepatocytes direct the formation of a pro-metastatic niche in the liver","volume":"567","author":"Lee","year":"2019","journal-title":"Nature."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0260","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1158\/1078-0432.CCR-18-2402","article-title":"Glioblastoma-derived IL6 induces immunosuppressive peripheral myeloid cell PD-L1 and promotes tumor growth","volume":"25","author":"Lamano","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0265","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.3760\/cma.j.issn.0366-6999.20122582","article-title":"An open-labeled, randomized, multicenter phase IIa study of gambogic acid injection for advanced malignant tumors","volume":"126","author":"Yihebali","year":"2013","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.aan4488","article-title":"Eradication of spontaneous malignancy by local immunotherapy","volume":"10","author":"Sagiv-Barfi","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0275","doi-asserted-by":"crossref","first-page":"eaan5692","DOI":"10.1126\/sciimmunol.aan5692","article-title":"A melanin-mediated cancer immunotherapy patch","volume":"2","author":"Ye","year":"2017","journal-title":"Science Immunology."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0280","doi-asserted-by":"crossref","first-page":"370ra180","DOI":"10.1126\/scitranslmed.aag2942","article-title":"Anti-PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM","volume":"8","author":"Mathios","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0285","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40902-021-00312-8","article-title":"A practical approach to orofacial rehabilitation in a patient after inferior maxillectomy and rhinectomy with mono framework construction supported on a zygomatic implant placed in the glabella: a case report","volume":"43","author":"Gaur","year":"2021","journal-title":"Maxillofac Plast Reconstr Surg."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0290","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1002\/1097-0142(19931201)72:11+<3515::AID-CNCR2820721619>3.0.CO;2-A","article-title":"Neoadjuvant therapy in cancer treatment","volume":"72","author":"Trimble","year":"1993","journal-title":"Cancer."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0295","doi-asserted-by":"crossref","first-page":"eaar1916","DOI":"10.1126\/scitranslmed.aar1916","article-title":"Extended release of perioperative immunotherapy prevents tumor recurrence and eliminates metastases","volume":"10","author":"Park","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2022.09.010_bb0300","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41571-019-0319-9","article-title":"Harnessing cancer immunotherapy during the unexploited immediate perioperative period","volume":"17","author":"Matzner","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922005946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922005946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:33:10Z","timestamp":1759163590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922005946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":60,"alternative-id":["S0168365922005946"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.09.010","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Local delivery of gambogic acid to improve anti-tumor immunity against oral squamous cell carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}